Prenatal And Newborn Genetic Testing Market Report 2026

Prenatal And Newborn Genetic Testing Market Overview

• Prenatal And Newborn Genetic Testing market size has reached to $7.6 billion in 2025 • Expected to grow to $13.65 billion in 2030 at a compound annual growth rate (CAGR) of 12.6% • Growth Driver: Rising Genetic Disorder Rates Drive Prenatal And Newborn Genetic Testing Market Growth • Market Trend: Innovative Advances In Prenatal And Newborn Genetic Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Prenatal And Newborn Genetic Testing Market?

Prenatal and newborn genetic testing refers to the medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are performed to detect and identify genetic disorders, congenital conditions, or hereditary diseases that may affect the child's health or development. The main product types of prenatal and newborn genetic testing are consumables and instruments. Instruments are specialized tools or devices designed for performing specific tasks or measurements that include various genetic analyzers that healthcare professionals use to conduct screenings and tests. The various types of screening include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The various diseases include Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These are used by various end-users such as hospitals, maternity, and specialty clinics, and diagnostic centers.

What Is The Prenatal And Newborn Genetic Testing Market Growth Forecast?

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $13.65 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising demand for early-stage disease detection, expansion of newborn screening mandates, growing investments in genomics infrastructure, increasing use of digital health platforms. Major trends in the forecast period include increasing adoption of non-invasive prenatal testing, rising use of advanced genetic screening panels, growing integration of ai in genetic risk analysis, expansion of high-throughput sequencing platforms, enhanced focus on early detection of congenital disorders.

Global Prenatal And Newborn Genetic Testing Market Segmentation

1) By Product Type: Consumables, Instruments 2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings 3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia 4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers Subsegments: 1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits 2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

What Is The Driver Of The Prenatal And Newborn Genetic Testing Market?

The rising incidence of genetic disorders is expected to propel the growth of the prenatal and newborn genetic testing market going forward. Genetic disorders refer to medical conditions resulting from abnormalities or mutations in an individual's DNA or genetic material. Prenatal and newborn genetic testing can identify genetic disorders at an early stage, often before symptoms manifest, enabling healthcare providers to initiate timely interventions and treatment strategies. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, sickle cell disease (SCD) affects about 100,000 people in the United States. More than 90% of those affected are non-Hispanic Black or African American, while an estimated 3%-9% are Hispanic or Latino. Therefore, the increasing prevalence of genetic disorders drives the prenatal and newborn genetic testing industry.

Key Players In The Global Prenatal And Newborn Genetic Testing Market

Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG

Global Prenatal And Newborn Genetic Testing Market Trends and Insights

Major companies operating in the prenatal and newborn genetic testing markets are focusing on developing innovative screening tests, such as noninvasive prenatal screening tests, with improved accessibility and affordability to provide reliable services to customers. Noninvasive prenatal screening (NIPS), or noninvasive prenatal testing (NIPT), is a highly advanced and safe genetic screening method performed during pregnancy to assess the risk of specific fetal chromosomal abnormalities. For instance, in January 2024, Natera, Inc., a US-based genetic testing company, launched a fetal RhD NIPT to determine fetal RhD status, helping obstetricians manage patient care during nationwide Rho(D) immune globulin (RhIg) shortages. The test is backed by a large clinical validation study including over 650 RhD-negative patients with confirmed outcomes, achieving 100% sensitivity and >99% specificity. Natera’s test can be performed early in pregnancy, supporting timely clinical decisions and improving patient management.

What Are Latest Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market?

In February 2024, CooperSurgical Inc., a US-based medical equipment manufacturing company, partnered with Fulgent Genetics. With this partnership, CooperSurgical aims to expand its portfolio by incorporating Fulgent Genetic's expertise in providing advanced genetic testing options for families utilizing the Cord Blood Registry. Fulgent Genetics Inc. is a US-based company that offers prenatal and newborn genetic testing.

Regional Outlook

North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Prenatal And Newborn Genetic Testing Market Report 2026?

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.